News about approval of omalizumab for treatment of Food Allergy
News about Palforzia (peanut oral immunotherapy) approval
To review publications from our group, please visit the individual investigator pages. For the latest news from our group, please visit our social media sites listed in the contact section.In a groundbreaking moment in the food allergy world, Children’s Healthcare of Atlanta’s Dr. Brian Vickery administered the first-ever dose of a new FDA-approved peanut allergy oral immunotherapy treatment for pediatric patients in March 2020. Two months prior, the FDA had approved the new oral immunotherapy, Palforzia, to treat children ages 4 to 17 with peanut allergy – making it the first and only FDA-approved treatment for any food allergy. Ian Bicknell, a 13-year-old Children’s food allergy patient, was the first pediatric patient nationwide to receive the therapy.